RxSight (RXST) EBITDA Margin (2020 - 2026)
RxSight's (RXST) quarterly EBITDA Margin came in at 57.71% in Q1 2026, down 2954.0% YoY from 2.02% in Q1 2025, and down 66.54% on a QoQ basis from 34.65% in Q4 2025.
RxSight (RXST) EBITDA Margin (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of EBITDA Margin data on file, last reported at 57.71% in Q1 2026.
- Quarterly EBITDA Margin fell 2954.0% year-over-year to 57.71% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 43.4% (down 1854.0% YoY) and the FY2025 annual result came in at 35.84%, down 947.0% from the prior year.
- EBITDA Margin retreated to 57.71% in Q1 2026, from 34.65% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 139.08% in Q2 2022 to a low of 312.46% in Q4 2023.
- A 5-year average of 32.42% and a median of 34.65% in 2025 frame the typical range for EBITDA Margin.
- The widest YoY moves for EBITDA Margin: up 42246 bps in 2022, down 117226 bps in 2022.
- Tracing RXST's EBITDA Margin over 5 years: stood at 93.18% in 2022, then slumped by 235 bps to 312.46% in 2023, then soared by 93 bps to 21.56% in 2024, then plunged by 61 bps to 34.65% in 2025, then slumped by 67 bps to 57.71% in 2026.
- The last three EBITDA Margin figures came in at 57.71% (Q1 2026), 34.65% (Q4 2025), and 40.21% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 19.15% |
| 10 | RxSight | 249.15 Mn | -155.09 Mn | - | -40.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -40.90% |
| Mar 31, 2026 | -57.71% |
| Dec 31, 2025 | -34.65% |
| Sep 30, 2025 | -40.21% |
| Jun 30, 2025 | -41.62% |
| Mar 31, 2025 | -28.17% |
| Dec 31, 2024 | -21.56% |
| Sep 30, 2024 | -26.13% |
| Jun 30, 2024 | -23.79% |
| Mar 31, 2024 | -36.15% |
| Dec 31, 2023 | -312.46% |
| Sep 30, 2023 | -56.36% |
| Jun 30, 2023 | 65.35% |
| Mar 31, 2023 | 74.90% |
| Dec 31, 2022 | -93.18% |
| Sep 30, 2022 | 126.83% |
| Jun 30, 2022 | 139.08% |
| Mar 31, 2022 | -185.39% |
| Dec 31, 2021 | 1,079.09% |
| Sep 30, 2021 | 226.41% |